// App-Quantinova.ai

: Recurrences after Splanchnic Vein Thrombosis: Risk Factors and Efficacy of Vitamin K‐Antagonists in a Retrospective Monocenter Cohort of 207 Patients

Researchers

Presenter

  • V. De Stefano

Principal Investigators

  • F. Bartolomei

  • S. Betti

  • A. Ciminello

  • T. Za

  • F. Di Landro

  • P. Chiusolo

  • E. Rossi

Medical Centers

  • Fondazione Policlinico A. Gemelli IRCCS, Istituto di Ematologia, Università Cattolica, Rome, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

  • Gastroenterology (GU)

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Extrahepatic portal vein obstruction

  • Venous thrombosis

  • Budd-Chiari syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved